Next Article in Journal
A New Deep-Learning-Based Model for Breast Cancer Diagnosis from Medical Images
Previous Article in Journal
Design and Development of IoT and Deep Ensemble Learning Based Model for Disease Monitoring and Prediction
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 13
Issue 11
10.3390/diagnostics13111943
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinical Characteristics of Patients with Intraocular Lens Calcification after Pars Plana Vitrectomy

by
Silvia Bopp
1,
Hüseyin Baran Özdemir
2,*,
Zeynep Aktaş
3,
Ramin Khoramnia
4,
Timur M. Yildirim
4,
Sonja Schickhardt
4,
Gerd U. Auffarth
4 and
Şengül Özdek
2
1
Capio Augenklinik Universitätsallee, 28213 Bremen, Germany
2
Department of Ophthalmology, Gazi University School of Medicine, Ankara 06570, Turkey
3
Department of Ophthalmology, Atilim University School of Medicine, Ankara 06830, Turkey
4
The David J Apple International Laboratory for Ocular Pathology, University of Heidelberg, 69117 Heidelberg, Germany
*
Author to whom correspondence should be addressed.
Diagnostics 2023, 13(11), 1943; https://doi.org/10.3390/diagnostics13111943
Submission received: 24 March 2023 / Revised: 21 April 2023 / Accepted: 28 May 2023 / Published: 1 June 2023
(This article belongs to the Section Pathology and Molecular Diagnostics)
Browse Figures
Review Reports Versions Notes

Abstract

:
Aim: To determine the clinical risk factors that may increase the occurrence of intraocular lens (IOL) calcification in patients who had undergone pars plana vitrectomy (PPV). Methods: The medical records of 14 patients who underwent IOL explantation due to clinically significant IOL opacification after PPV were reviewed. The date of primary cataract surgery, technique and implanted IOL characteristics; the time, cause and technique of PPV; tamponade used; additional surgeries; the time of IOL calcification and explantation; and IOL explantation technique were investigated. Results: PPV had been performed as a combined procedure with cataract surgery in eight eyes and solely in six pseudophakic eyes. The IOL material was hydrophilic in six eyes, hydrophilic with a hydrophobic surface in seven eyes and undetermined in one eye. The endotamponades used during primary PPV were C2F6 in eight eyes, C3F8 in one eye, air in two eyes and silicone oil in three eyes. Two of three eyes underwent subsequent silicone oil removal and gas tamponade exchange. Gas in the anterior chamber was detected in six eyes after PPV or silicone oil removal. The mean interval between PPV and IOL opacification was 20.5 ± 18.6 months. The mean BCVA in logMAR was 0.43 ± 0.42 after PPV, which significantly decreased to 0.67 ± 0.68 before IOL explantation for IOL opacification (p = 0.007) and increased to 0.48 ± 0.59 after the IOL exchange (p = 0.015). Conclusions: PPV with endotamponades in pseudophakic eyes, particularly gas, seems to increase the risk for secondary IOL calcification, especially in hydrophilic IOLs. IOL exchange seems to solve this problem when clinically significant vision loss occurs.

1. Introduction

Opacification due to calcification of intraocular lenses (IOL) is a rare but severe complication and may need IOL exchange [1]. Calcification of hydrophilic acrylic IOLs has been a well-known phenomenon since 1999, but the mechanism is not fully understood yet. Calcification is classified as primary, secondary and pseudo-calcification [2]. Whereas primary opacifications are inherent to the IOL itself, mainly to the IOL material, manufacturing or packaging problems [3,4], secondary opacifications are thought to occur as a result of environmental factors, such as ocular inflammation and foreign materials in the anterior chamber like air, gas or silicone oil and were suggested to increase the risk of IOL calcifications [5,6].
Opacification has been more frequently reported in hydrophilic acrylic IOLs. Hydrophilic acrylic IOLs with hydrophobic surface were designed to decrease primary calcification, but the occurrence of calcification in these IOLs has also been reported recently [4,7]. Increasing numbers of cataract surgeries and secondary interventions such as posterior lamellar keratoplasty (DMEK and DSAEK) necessitating intracameral injection of air or gas also resulted in growing numbers of IOL opacification cases. Another risk factor is pars plana vitrectomy (PPV) with gas tamponade leaking into the anterior chamber. IOL calcification was previously reported to occur following PPV with sulphur hexafluoride (SF6), perfluoropropane (C3F8) and air [8,9,10].
IOL opacification may cause a decrease in visual acuity and contrast sensitivity [11,12]. Significant opacification of the IOL optic causes visual deterioration, and the only treatment is IOL explantation. As the capsular bag cannot be opened and the diaphragm cannot be preserved in all cases, secondary IOLs must be placed in the sulcus (with or without suturing) or fixed to the iris (iris claw type anterior to or behind the iris).
Here, we report clinical findings of calcified IOLs that occurred following PPV and were explanted due to progressive visual impairment. The aim of the study was to investigate the factors that may increase the risk of calcification and the time interval between PPV and IOL opacification.

2. Materials and Methods

This retrospective study included 14 patients who underwent IOL explantation due to clinically significant IOL opacifications after PPV in two tertiary referral centres (Bremen Eye Clinic Universitätsallee, Bremen, Germany and Department of Ophthalmology, Gazi University, Ankara, Turkey) between June 2015 and July 2017. Extracted IOLs were sent to and analysed at the David J Apple International Laboratory for Ocular Pathology, Department of Ophthalmology, University of Heidelberg. The study protocol was approved by the local Ethics Committee of Gazi University. The study was conducted in compliance with the tenets of the Declaration of Helsinki. Informed consent was taken from all patients before surgery.
The medical charts of all patients were reviewed in detail. The following data were collected from medical records: age, sex, systemic diseases, coexisting ophthalmic diseases, the date of IOL implantation, implanted IOL design/material/brand/dioptre, the date of vitrectomy, vitrectomy indication, vitrectomy manoeuvres and tamponades, presence of the postoperative intracameral gas, additional surgeries after vitrectomy, the date when IOL opacification was recorded first, location of IOL opacification, the time interval between vitrectomy and IOL opacification, the time interval between IOL opacification and IOL explantation, the new IOL design/material/brand/dioptre implanted, best corrected visual acuity (BCVA) after vitrectomy, prior to IOL explantation and after IOL exchange, posterior capsule data such as previously performed YAG-laser capsulotomy or intraoperative capsulotomy.
A review of the reports of the previous surgeries has revealed that either conventional 20-gauge or transconjunctival 23-gauge PPV had been performed as a single procedure in pseudophakic eyes or as combined surgery with phacoemulsification and in-the-bag IOL implantation in primary phakic eyes. Air, C2F6, C3F8 or silicone oil had been used as endotamponade agents.
IOL explantation was performed in patients who had a loss of vision due to IOL calcification. The first step of the surgery was trying to free the IOL from the capsular apparatus. If capsular adhesions were too firm and/or the capsular bag was already weak, the IOL and capsule were extracted together through a corneoscleral incision. A new three-piece IOL was implanted into the sulcus in the eyes with sufficient capsular support. If an adequate capsular diaphragm was not present, the three-piece IOL was sutured to the sclera or an iris-fixated IOL was used.
All intraocular lenses were sent for analysis by the surgeon to the David Apple International Laboratory for Ocular Pathology, University of Heidelberg, Germany. The methodology of analysis is described in detail by Yildirim et al. [13]. In short, after microscopic examination, the IOLs were stained with Alizarin red for detection of superficial calcium deposits. Of note, 5 µm vertical cross sections from the optical centre of the lens were stained using the von Kossa method to find subsurface calcium deposits [13].
Statistical analyses were performed with SPSS 22.0 (IBM, Armonk, NY, USA). The Student t-test was used to compare Snellen visual acuity results.

3. Results

The demographic data of 14 eyes of 14 patients with IOL opacification are presented in Table 1. The mean age of patients was 54.10 ± 15.50 and the female/male ratio was 6/8. Thirteen out of 14 IOLs were made of hydrophilic acrylic material (7/13 with hydrophobic coating), and one IOL’s specifications were unknown but showed the same opacification pattern. Six out of 14 IOLs had plate haptics, seven of 14 IOLs had C-loop haptics, and one IOL had prolene haptics. The mean IOL dioptres were 18.23 ± 3.34 D (range: 13.00–26.50 D).
Eight eyes had undergone simultaneous phacoemulsification, IOL implantation and PPV surgery (Table 2). The remaining six eyes were pseudophakic, and PPV was performed after a mean of 43.4 months after cataract surgery (range: 2–108 months). Indication for PPV was pseudophakic rhegmatogenous retinal detachment (RRD) in six eyes (42.85%), phakic RRD in six eyes (42.85%), tractional retinal detachment in a uveitis patient (7.15%) and macular surgery for an epiretinal membrane in one patient (7.15%). C2F6 gas tamponade was used in eight eyes, C3F8 was used in one eye, air was used in two eyes, and silicone oil was used in three eyes. One patient who was given an air endotamponade underwent repeat vitrectomy with silicone oil tamponade.
Patients with silicone oil underwent subsequent silicone oil removal and gas tamponade with C3F8, SF6 or air. Postoperatively after primary vitrectomy, intracameral gas was detected in six eyes (42.85%). Two patients required YAG-laser iridotomy for a pupillary block due to gas in the anterior chamber, and two patients underwent anterior chamber revision with gas removal. Five patients had received an intraoperative posterior capsulotomy during primary surgery with air/gas, and another one had already a YAG-capsulotomy before RRD surgery. An additional three eyes received Nd:YAG-laser capsulotomy in the later postoperative course. Including silicone oil removal, additional vitreoretinal procedures were performed in six patients. One of six patients underwent four consecutive vitreoretinal surgeries. Repeat vitrectomy was performed in another two patients, and one of these patients underwent silicone oil removal later. The remaining three patients underwent further silicone oil–air/gas exchange.
The clinical data before and after the detection of IOL calcification are presented in Table 3. The mean interval between the first PPV and documented IOL opacification was 17.8 ± 15.4 months (2–54 months). The mean interval between first air/gas contact with IOL and documented IOL opacification was 16.90 ± 15.70 months (2–54 months). The mean LogMAR BCVA after PPV was 0.43 ± 0.42 (0.00–1.30), and the mean BCVA before IOL explantation due to IOL opacification was 0.67 ± 0.68 (0.1–2.70). The decrease in BCVA was statistically significant (p = 0.007). The mean BCVA increased again to 0.48 ± 0.59 LogMAR (0.00–2.30) following the IOL exchange. The increase in BCVA after IOL exchange was statistically significant (p = 0.015). There was no statistically significant difference between the initial BCVA before IOL calcification and the BCVA after the IOL exchange, indicating that the mean vision returned to the original level following the IOL exchange (p = 0.905).
Central opacification of IOLs was demonstrated at the slit-lamp examination (Figure 1 and Figure 2). Nine of 14 IOLs (64.28%) had opacification at the anterior surface, and two of 14 IOLs (14.28%) had opacification at the posterior surface. The David J Apple International Laboratory for Ocular Pathology examined and identified calcium phosphate deposits in all IOLs located within the pupillary area, always sparing the haptic and sometimes the peripheral optic (Figure 3).

4. Discussion

The present study focused on the clinical data of the patients who underwent IOL explantation for opacifications that occurred after PPV. We assume that there are many unrecorded or misdiagnosed cases, the latter receiving YAG-laser capsulotomy for the misdiagnosis of after-cataract. The opacifications are caused by superficial calcium deposits at the surface of the IOL. They are located in the pupillary area, usually at the anterior surface, less common at the posterior surface. Calcifications can occur in a very short time period (within two months) or may be seen as a late complication (after 54 months) [5,14,15]. Visual deterioration was recorded on average 20.5 months after PPV in our study. Analysis of clinical data indicates that intravitreal gas or air tamponade increases the risk of IOL calcification in eyes with both hydrophilic IOLs and hydrophilic IOLs with a hydrophobic surface. The presence of gas/air in the anterior chamber and a posterior capsulotomy that enables direct contact of intravitreal gas/air to the IOL surface seems to be a predisposing factor for IOL calcifications. Some of our patients had primary vitrectomy with silicone oil and developed IOL calcifications thereafter. When reviewing the medical history, all eyes had at least once gas/air in the eye during the postoperative course. Thus, the beginning of the structural changes in the IOL was most likely attributable to the air/gas and not to the primary silicone oil tamponade.
There are very few cases published reporting IOL calcification after PPV with silicone oil tamponade [16,17,18]. In the majority of them, IOL opacification occurred after silicone oil removal. In view of known risk factors, it cannot be judged with certainty whether silicone oil itself or accompanying factors (see below) provoked calcification. We have observed a few diabetic patients with a silicone oil tamponade and some central calcifications at the lens surface who did not accept lens exchange which was followed for a couple of years without significant progression (Figure 4).
Calcification of IOLs is a known phenomenon first reported by Apple et al. in 2000 [19]. The reports and laboratory analysis of the explanted IOLs showed that the opacifications consist of calcium phosphate/hydroxyapatite deposits at the IOL surface [13]. The exact pathophysiology leading to those accumulations on the IOL surface remains a matter of discussion. Supersaturation of humor aqueous with calcium may lead to precipitations at the IOL and initiate deposition of microcrystals that may enlarge thereafter. It occurs with hydrophilic acrylic IOLs with hydroxyl groups at the surface and can bind calcium compounds, but hydrophilic IOLs with hydrophobic coating may also show calcification. The causes and the alterations of the intraocular milieu triggering the deposition of calcium phosphate are not known. It is hypothesized that foreign material, such as a gas tamponade, intraocular inflammation or specific topical medication may initiate this process. Most likely the mechanism is multifactorial [3,15,20].
After the 2000s, manufacturing-related calcifications emerged in some specific types of IOLs, which were classified as being primary calcification [2,21,22,23,24]. Material and manufacturing processes, as well as packaging and storage problems, may increase the risk of calcium and phosphate depositions into the IOL [1]. Manufacturers withdrew those lenses from the market and changed manufacturing or packaging methods. Furthermore, a coating of the hydrophilic material with hydrophobic material was developed to overcome this problem. However, the calcification of these coated IOLs has also been observed [4,7]. Our patients had various types of IOLs with different designs and materials (Table 4). Thirteen of 14 IOLs in our series were hydrophilic, and interestingly, seven of them had a hydrophobic coating. Twelve of 14 IOLs were single-piece IOLs (plate haptic and C-loop design), and one of the IOLs had a three-piece design. Therefore, the risk of calcification is increased in the hydrophilic IOL material but not affected by the IOL design.
As secondary calcifications of hydrophilic IOLs are extremely rare after uneventful cataract surgery, other factors than the IOL material alone must be causative. One particular finding is the presence of intraocular air/gas with temporary contact with the IOL, which was a uniform finding in our patients. In analogy to that, there are several reports of IOL calcifications that occurred after posterior lamellar keratoplasty [5,25,26,27]. The use of air or gas for the attachment of the graft is thought to be associated with IOL calcification in the presence of a hydrophilic acrylic IOL. Repeat intracameral gas or air injections (rebubbling) increases the risk of IOL calcifications [28,29]. The same is valid for other clinical situations, such as intracameral gas or air injection for Descemet membrane detachment, for wound sealing after cataract surgery and gas dislocation from the vitreous cavity into the anterior chamber [30,31]. In total, at least eight out of 14 eyes had contact of gas to the anterior or posterior lens surface via a capsulotomy or due to gas dislocation. Thus, the presence of gas and probably direct contact with the IOL can be considered as an important trigger for secondary IOL calcifications. Recently, Marcovic et al. analysed 11 cases with similar clinical characteristics [32]. All had undergone vitrectomy and gas tamponade for either macular diseases or RRDs. The authors speculated that intraocular gas might dehydrate the hydrophilic IOL, irrespective of direct contact of gas with the IOL or capsule and then leading to changes in the IOL surface that make it prone to calcium phosphate sedimentations. As most reports did not analyse details of the lens capsule or a possible gas prolapse, the role of a posterior capsulotomy could not be assessed with certainty at present [9,10,14,33].
Surgical inflammation caused by vitrectomy, retinopexy and tamponade agents leads to a breakdown of the blood–aqueous barrier to some extent in all eyes. Most cases of IOL calcification after PPV were reported to have previous combined phacoemulsification and vitrectomy [9,16,17,18,34,35]. Even if clinically not relevant, combined phacoemulsification and vitrectomy is accompanied by more postoperative inflammation compared to vitrectomy alone [35]. Similarly, eight (57%) of the cases in our series had undergone combined surgery. Although secondary IOL calcifications are extremely rare after uneventful cataract surgery, cases with enhanced-inflammation-received intracameral rt-PA (recombinant tissue plasminogen activator) to treat fibrin formation were shown to develop calcium depositions [36], which stresses the fact that enhanced inflammation is an essential trigger for calcium deposition.
Inflammation may be even more pronounced in diabetes-related ocular pathologies [37]. Park et al. reported five cases of IOL calcification in eyes with proliferative diabetic retinopathy-related vitreous haemorrhage that underwent PPV [34]. However, there were no patients with diabetic ocular changes in our cohort and none in the series reported by Marcovic [32].
Additional vitreoretinal procedures such as repeat vitrectomy or silicone oil removal, which were performed in 43% (six eyes) of our patients, may induce another episode of intraocular inflammatory reaction. The risk of IOL calcification should be kept in mind when repeat vitreoretinal surgeries are needed in pseudophakic patients.
Visually significant IOL calcification requires IOL explantation. Exchange with a new in-the-bag IOL is usually not possible due to fibrotic capsular bag adhesions, advanced after-cataract and zonular weakening. Therefore, secondary IOLs are usually implanted into the sulcus when the capsule can be preserved or fixed with sutures to the sclera or iris or fixed to the iris using an iris claw lens. IOL exchange with a scleral-fixated type was the preferred technique in most of our patients. Although visual acuity increased significantly and usually reached the best corrected vision before the calcification, it must be kept in mind that the long-term compatibility of such IOLs is not as good as primary in-the-bag implants.
In conclusion, the pathogenesis of secondary IOL calcifications appears to be multifactorial. IOL material, use of intravitreal/gas/air tamponade, combined phacovitrectomy, the presence of air/gas in the anterior chamber, posterior capsulotomy and postoperative inflammation may be identified as risk factors for this complication. Clinically, calcium phosphate deposits developing after vitrectomy share many features with opacifications occurred after anterior segment surgeries, and intraocular inflammation and the presence of gas seem to be of the most significance. Hydrophilic IOLs should be avoided in patients undergoing combined phacovitrectomy as a precaution. IOL explantation and exchange seem to be an effective approach for visual rehabilitation in cases with significant calcifications.

Author Contributions

Conceptualisation, S.B. and Ş.Ö.; methodology, S.B., H.B.Ö., Ş.Ö. and Z.A.; formal analysis, S.B., R.K. and G.U.A.; investigation, S.B., H.B.Ö. and Ş.Ö.; data curation, R.K., T.M.Y., S.S. and G.U.A.; writing—original draft preparation, S.B., H.B.Ö. and Ş.Ö.; writing—review and editing, S.B., Z.A., R.K., T.M.Y., S.S., G.U.A. and Ş.Ö. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the local Ethics Committee of Gazi University (Approval Code: 2021-564).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data presented in the manuscript are available from the corresponding authors upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Werner, L. Causes of intraocular lens opacification or discoloration. J. Cataract. Refract. Surg. 2007, 33, 713–726. [Google Scholar] [CrossRef] [PubMed]
  2. Neuhann, I.M.; Kleinmann, G.; Apple, D.J. A New Classification of Calcification of Intraocular Lenses. Ophthalmology 2008, 115, 73–79. [Google Scholar] [CrossRef]
  3. Giers, B.C.; Tandogan, T.; Auffarth, G.U.; Choi, C.Y.; Auerbach, F.N.; Sel, S.; Mayer, C.; Khoramnia, R. Hydrophilic intraocular lens opacification after posterior lamellar keratoplasty—A material analysis with special reference to optical quality assessment. BMC Ophthalmol. 2017, 17, 150. [Google Scholar] [CrossRef]
  4. Gartaganis, S.P.; Prahs, P.; Lazari, E.D.; Gartaganis, P.S.; Helbig, H.; Koutsoukos, P.G. Calcification of Hydrophilic Acrylic Intraocular Lenses with a Hydrophobic Surface: Laboratory Analysis of 6 Cases. Am. J. Ophthalmol. 2016, 168, 68–77. [Google Scholar] [CrossRef] [PubMed]
  5. Schrittenlocher, S.; Penier, M.; Schaub, F.; Bock, F.; Cursiefen, C.; Bachmann, B. Intraocular Lens Calcifications After (Triple-) Descemet Membrane Endothelial Keratoplasty. Am. J. Ophthalmol. 2017, 179, 129–136. [Google Scholar] [CrossRef] [PubMed]
  6. Katsimpris, J.M.; Theoulakis, P.E.; Kouzi-Koliakos, K.; Pavlidou, E.; Petropoulos, I.K.; Koliakos, G.; Vouroutzis, N.; Konstas, A.G. Late Postoperative Opacification of Hydrogel Intraocular Lenses: Analysis of 13 Explanted Lenses. Klin. Monbl. Augenheilkd. 2009, 226, 264–271. [Google Scholar] [CrossRef]
  7. Bompastor-Ramos, P.; Póvoa, J.; Lobo, C.; Rodriguez, A.E.; Alió, J.L.; Werner, L.; Murta, J.N. Late postoperative opacification of a hydrophilic–hydrophobic acrylic intraocular lens. J. Cataract. Refract. Surg. 2016, 42, 1324–1331. [Google Scholar] [CrossRef] [PubMed]
  8. Dhital, A.; Spalton, D.J.; Goyal, S.; Werner, L. Calcification in Hydrophilic Intraocular Lenses Associated with Injection of Intraocular Gas. Am. J. Ophthalmol. 2012, 153, 1154–1160.e1. [Google Scholar] [CrossRef]
  9. Walker, N.J.; Saldanha, M.J.; Sharp, J.A.; Porooshani, H.; McDonald, B.M.; Ferguson, D.; Patel, C.K. Calcification of hydrophilic acrylic intraocular lenses in combined phacovitrectomy surgery. J. Cataract. Refract. Surg. 2010, 36, 1427–1431. [Google Scholar] [CrossRef]
  10. Khurana, R.; Werner, L. Calcification of a hydrophilic acrylic intraocular lens after pars plana vitrectomy. Retin. Cases Brief Rep. 2016, 12, 204–206. [Google Scholar] [CrossRef]
  11. Michelson, J.; Werner, L.; Ollerton, A.; Leishman, L.; Bodnar, Z. Light scattering and light transmittance in intraocular lenses explanted because of optic opacification. J. Cataract. Refract. Surg. 2012, 38, 1476–1485. [Google Scholar] [CrossRef]
  12. Fernando, G.T.; Crayford, B.B. Visually significant calcification of hydrogel intraocular lenses necessitating explantation. Clin. Exp. Ophthalmol. 2000, 28, 280–286. [Google Scholar] [CrossRef]
  13. Yildirim, T.M.; Auffarth, G.U.; Łabuz, G.; Bopp, S.; Son, H.-S.; Khoramnia, R. Material Analysis and Optical Quality Assessment of Opacified Hydrophilic Acrylic Intraocular Lenses After Pars Plana Vitrectomy. Am. J. Ophthalmol. 2018, 193, 10–19. [Google Scholar] [CrossRef] [PubMed]
  14. Rahimi, M.; Azimi, A.; Hosseinzadeh, M. Intraocular lens calcification: Clinico-pathological report of two cases and literature review. J. Ophthalmic Vis. Res. 2018, 13, 195–199. [Google Scholar] [CrossRef] [PubMed]
  15. Werner, L.; Wilbanks, G.; Nieuwendaal, C.P.; Dhital, A.; Waite, A.; Schmidinger, G.; Lee, W.B.; Mamalis, N. Localized opacification of hydrophilic acrylic intraocular lenses after procedures using intracameral injection of air or gas. J. Cataract. Refract. Surg. 2015, 41, 199–207. [Google Scholar] [CrossRef] [PubMed]
  16. Stoffelns, B.M.; Goetz, H. Opacification of a hydrophilic intraocular lens due to calcification after silicone oil surgery. Klin. Monbl. Augenheilkd. 2014, 231, 315–317. [Google Scholar]
  17. Chronopoulos, A.; Varga, Z.; Steinfeld, P.A.; Dahlmann, R.; Jukic, T.; Walter, P.; Thumann, G. Unusual IOL Calcification following Vitreoretinal Surgery with Silicone Oil Endotamponade. Klin. Monbl. Augenheilkd. 2015, 232, 779–784. [Google Scholar]
  18. Rosca, C.; Munteanu, M.; Tamasoi, I.; Petrovic, Z.; Balica, N.; Nicula, C.; Cretu, O. Calcification of hydrophilic acrylic intraocular lens in eyes with silicone oil tamponade—An interventional case series report. Acta Ophthalmol. 2016, 94, 625–627. [Google Scholar] [CrossRef]
  19. Apple, D.J.; Werner, L.; Escobar-Gomez, M.; Pandey, S.K. Deposits on the Optical Surfaces of Hydroview Intraocular Lenses. J. Cataract. Refract. Surg. 2000, 26, 796–797. [Google Scholar] [CrossRef]
  20. Mojzis, P.; Studeny, P.; Werner, L.; Piñero, D.P. Opacification of a hydrophilic acrylic intraocular lens with a hydrophobic surface after air injection in Descemet-stripping automated endothelial keratoplasty in a patient with Fuchs dystrophy. J. Cataract. Refract. Surg. 2016, 42, 485–488. [Google Scholar] [CrossRef]
  21. Werner, L.; Apple, D.J.; Escobar-Gomez, M.; Öhrström, A.; Crayford, B.B.; Bianchi, R.; Pandey, S.K. Postoperative deposition of calcium on the surfaces of a hydrogel intraocular lens. Ophthalmology 2000, 107, 2179–2185. [Google Scholar] [CrossRef]
  22. Izak, A.M.; Werner, L.; Pandey, S.K.; Apple, D.J. Calcification of modern foldable hydrogel intraocular lens designs. Eye 2003, 17, 393–406. [Google Scholar] [CrossRef] [PubMed]
  23. Tehrani, M.; Mamalis, N.; Wallin, T.; Dick, B.H.; Stoffelns, B.M.; Olson, R.; Fry, L.L.; Clifford, W.S. Late postoperative opacification of MemoryLens hydrophilic acrylic intraocular lenses Case series and review. J. Cataract. Refract. Surg. 2004, 30, 115–122. [Google Scholar] [CrossRef] [PubMed]
  24. Syam, P.; Byrne, P.; Lewis, G.; Husain, T.; Kleinmann, G.; Mamalis, N.; Apple, D.J.; Rimmer, T. Hydroview lens implant calcification: 186 exchanges at a district general hospital. Eye 2008, 22, 325–331. [Google Scholar] [CrossRef] [PubMed]
  25. Neuhann, I.M.; Neuhann, T.F.; Rohrbach, J.M. Intraocular Lens Calcification After Keratoplasty. Cornea 2013, 32, e6–e10. [Google Scholar] [CrossRef] [PubMed]
  26. Fellman, M.A.; Werner, L.; Liu, E.T.; Stallings, S.; Floyd, A.M.; van der Meulen, I.J.; Lapid-Gortzak, R.; Nieuwendaal, C.P. Calcification of a hydrophilic acrylic intraocular lens after Descemet-stripping endothelial keratoplasty: Case report and laboratory analyses. J. Cataract. Refract. Surg. 2013, 39, 799–803. [Google Scholar] [CrossRef]
  27. Maier, P.C.; Heinzelmann, S.; Bohringer, D.; Reinhard, T. Intraocular Lens Opacification Following Posterior Lamellar Keratoplasty. Klin. Monbl. Augenheilkd. 2015, 232, 976–981. [Google Scholar]
  28. De Cock, R.; Fajgenbaum, M.A.P. Calcification of Rayner hydrophilic acrylic intra-ocular lenses after Descemet’s stripping automated endothelial keratoplasty. Eye 2014, 28, 1383–1384. [Google Scholar] [CrossRef]
  29. Morgan-Warren, P.; Andreatta, W.; Patel, A. Opacification of hydrophilic intraocular lenses after Descemet stripping automated endothelial keratoplasty. Clin. Ophthalmol. 2015, 9, 277–283. [Google Scholar] [CrossRef]
  30. Saeed, M.U.; Singh, A.J.; Morrell, A.J. Sequential Descemet’s membrane detachments and intraocular lens haze secondary to SF6 or C3F8. Eur. J. Ophthalmol. 2006, 16, 758–760. [Google Scholar] [CrossRef]
  31. Ventura, B.V.; MacLean, K.D.; Lira, W.; Oliveira, D.M.; Ventura, C.V.; Werner, L. Microscopic analysis of an opacified OFT CRYL(R) hydrophilic acrylic intraocular lens. Arq. Bras. Oftalmol. 2016, 79, 255–257. [Google Scholar] [CrossRef] [PubMed]
  32. Marcovich, A.L.; Tandogan, T.; Bareket, M.; Eting, E.; Kaplan-Ashiri, I.; Bukelman, A.; Auffarth, G.U.; Khoramnia, R. Opacification of hydrophilic intraocular lenses associated with vitrectomy and injection of intraocular gas. BMJ Open Ophthalmol. 2018, 3, e000157. [Google Scholar] [CrossRef] [PubMed]
  33. Cao, D.; Zhang, H.; Yang, C.; Zhang, L. Akreos Adapt AO Intraocular lens opacification after vitrectomy in a diabetic patient: A case report and review of the literature. BMC Ophthalmol. 2016, 16, 82. [Google Scholar] [CrossRef]
  34. Park, D.H.; Shin, J.P.; Kim, H.K.; Kim, J.H.; Kim, S.Y. Hydrophilic acrylic intraocular lens (Akreos AO MI60) optic opacification in patients with diabetic retinopathy. Br. J. Ophthalmol. 2010, 94, 1688–1689. [Google Scholar] [CrossRef] [PubMed]
  35. Lee, S.J.; Choi, J.H.; Sun, H.J.; Choi, K.S.; Jung, G.Y. Surface calcification of hydrophilic acrylic intraocular lens related to inflammatory membrane formation after combined vitrectomy and cataract surgery. J. Cataract. Refract. Surg. 2010, 36, 676–681. [Google Scholar] [CrossRef]
  36. Fung, S.S.M.; Sykakis, E.; Islam, N.M.; Zambarakji, H.J.; Khoramnia, R.; Auffarth, G.; Parmar, D.N. Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery. J. Ophthalmol. 2015, 2015, 975075. [Google Scholar] [CrossRef]
  37. Chen, H.; Zhang, X.; Liao, N.; Wen, F. Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy. BMC Ophthalmol. 2017, 17, 176. [Google Scholar] [CrossRef]
Diagnostics 13 01943 g001 550
Figure 1. Different densities of superficial opacifications of hydrophilic IOLs in vitrectomized eyes. Treatment included: (A) Combined phaco-vitrectomy for proliferative diabetic retinopathy (Acri.Lyc 51LC). (B) Vitrectomy and C2F6-gas tamponade combined with phaco/capsular-bag-fixated IOL for retinal detachment (Basis Z). (C) Pseudophakic vitrectomy and air tamponade for uveitis (Hydroview H60M). (D) fundus image of the same eye (C) that shows the clouding effect of the IOL.
Figure 1. Different densities of superficial opacifications of hydrophilic IOLs in vitrectomized eyes. Treatment included: (A) Combined phaco-vitrectomy for proliferative diabetic retinopathy (Acri.Lyc 51LC). (B) Vitrectomy and C2F6-gas tamponade combined with phaco/capsular-bag-fixated IOL for retinal detachment (Basis Z). (C) Pseudophakic vitrectomy and air tamponade for uveitis (Hydroview H60M). (D) fundus image of the same eye (C) that shows the clouding effect of the IOL.
Diagnostics 13 01943 g001
Diagnostics 13 01943 g002 550
Figure 2. Pre- and intraoperative findings of two eyes that needed IOL exchange for dense IOL calcifications. Phaco-vitrectomy with C2F6-gas was performed for retinal detachment using an AcriSmart IOL (previous Acri.Tec, now Zeiss Asphina) (A,B—case 4) and Basis Z (1st Q, Mannheim—case 11) (C,D). Note that the deposits are located in the pupillary area, but the haptics are spared.
Figure 2. Pre- and intraoperative findings of two eyes that needed IOL exchange for dense IOL calcifications. Phaco-vitrectomy with C2F6-gas was performed for retinal detachment using an AcriSmart IOL (previous Acri.Tec, now Zeiss Asphina) (A,B—case 4) and Basis Z (1st Q, Mannheim—case 11) (C,D). Note that the deposits are located in the pupillary area, but the haptics are spared.
Diagnostics 13 01943 g002
Diagnostics 13 01943 g003 550
Figure 3. Material analysis of one of the calcified intraocular lenses (case No. 11, B1AW00 Basis Z, 1stQ, Mannheim, Germany): Dense opacification of the anterior IOL optic sparing the haptics (A). Alizarin red staining of one half of the IOL stains superficial calcium deposits (B). Von Kossa staining of a 5 µm cross section of the IOL reveals calcium deposits underneath the IOL surface within the lens material (C).
Figure 3. Material analysis of one of the calcified intraocular lenses (case No. 11, B1AW00 Basis Z, 1stQ, Mannheim, Germany): Dense opacification of the anterior IOL optic sparing the haptics (A). Alizarin red staining of one half of the IOL stains superficial calcium deposits (B). Von Kossa staining of a 5 µm cross section of the IOL reveals calcium deposits underneath the IOL surface within the lens material (C).
Diagnostics 13 01943 g003
Diagnostics 13 01943 g004 550
Figure 4. Anterior segment photography of a diabetic patient who underwent combined phaco-vitrectomy with silicone oil tamponade for proliferative diabetic retinopathy. Opacification of the anterior side of the IOL optic was observed, but it did not cause remarkable visual deterioration (BCVA: 20/30). The patient was followed up on without an IOL exchange surgery for two years.
Figure 4. Anterior segment photography of a diabetic patient who underwent combined phaco-vitrectomy with silicone oil tamponade for proliferative diabetic retinopathy. Opacification of the anterior side of the IOL optic was observed, but it did not cause remarkable visual deterioration (BCVA: 20/30). The patient was followed up on without an IOL exchange surgery for two years.
Diagnostics 13 01943 g004
Table
Table 1. Demographics of the patient cohort.
Table 1. Demographics of the patient cohort.
Patient No.Age (at IOL İmplantation)SexSystemic DiseasesDate of IOL İmplantationIOL Type/ManufacturerIOL Diopters
No. 160FemaleHT, CHDFeb. 2013CT Asphina 409M (Zeiss)13.00
No. 218MaleHealthyMay 2016 CT Asphina 409M (Zeiss)20.00
No. 355FemaleHT, HLMar. 2014 CT Asphina 409M (Zeiss)18.50
No. 459MaleHT, CHDSep. 2011 CT Asphina 409M (Zeiss)16.50
No. 578FemaleHT, arthritis,
allergic rhinitis		Jun. 2012 B1AW00 Basis Z (1stQ)19.50
No. 641MaleHTOct. 2010C-flex 970C (Rayner)26.50
No. 769MaleHT, COPD, HL, stroke, renal insuffiencyJan. 2015 B1AW00 Basis Z (1stQ)19.50
No. 847MaleHealthyApr. 2011B1AW00 Basis Z (1stQ)16.50
No. 970FemaleHT, arthritis, hypothyroidism2007AcriLyc 44S (Zeiss)19.50
No. 1071FemaleCardiac arrhythmia, bronchitis, hypothyroidismJuly 2014Polylens AS61 (Polytech Domilens)18.00
No. 1149FemaleLatex allergyFeb. 2014 B1AW00 Basis Z (1stQ)19.00
No. 1242MaleHealthyNov. 2012Acriva UD613 (VSY)13.50
No. 1351MaleHealthyJul. 2009 Acriva UD613 (VSY)17.00
No. 1448MaleHealthy2008UnknownUnknown
HT: Systemic hypertension, CHD: Coronary heart disease, HL: Hyperlipidemia, COPD: Chronic obstructive pulmonary disease.
Table
Table 2. Clinical and surgical features of patients.
Table 2. Clinical and surgical features of patients.
Patient No.PPV
Indication		Date of PPVVitrectomy
Maneuvers		Post-Op Intra-Camaral GasAdditional Surgeries
(Except IOL Removal or Exchange)		Diagnosis of IOL Opacification
No. 1Pseudophakic RRDMay 2013PPV, post. capsulotomy, ILMP with ICG, PFCL, EL, C2F6YesJune 2013: Nd:YAG-laser iridotomy for pupillary blockJuly 2013
No. 2TRD in uveitisMay 2016Phaco-IOL, PPV, ILMP, PFCL, EL, silicone oilNoAug. 2016: SBS, silicone oil removal, EL, C3F8Nov. 2016
No. 3Phakic RRDMar. 2014Phaco-IOL, PPV, ILMP with ICG, PFCL, EL, C2F6YesMar. 2014: Nd:YAG-laser iridotomy for pupillary block; July 2014: Nd:YAG-laser capsulotomyMay 2016
No. 4Phakic RRDSep. 2011Phaco-IOL, PPV, ILMP with ICG, PFCL, EL, C2F6NoNoneApril 2013
No. 5Phakic RRDJun. 2012Phaco-IOL, PPV, post. capsulotomy, ILMP with ICG, PFCL, EL, C2F6NoNoneDec. 2016
No. 6Pseudophakic RRDDec. 2014PPV, ILMP with ICG, PFCL, EL, C2F6NoPre-operative Nd:YAG-laser capsulotomyDec. 2015
No. 7Epiretinal gliosis after PPVJan. 2015Phaco-IOL, PPV, post. capsulotomy, ILMP with ICG, PFCL, EL, airNoJan. 2015: Repeat PPV, PFCL, EL, C2F6Mar. 2017
No. 8Pseudophakic RRDNov. 2013PPV, post. capsulotomy, ILMP with ICG, PFCL, EL, C2F6YesNoneJan. 2014
No. 9Phakic RRDDec. 2016Phaco-IOL, PPV, ILMP with ICG, PFCL, EL, C2F6No dataRepeat PPV with heavy silicone tamponade; silicone oil removal and C2F6 tamponade (in total: four additional surgeries)No data (surgeries elsewhere)
No. 10Pseudophakic RRDSep. 2016PPV, EL, heavy silicone oilYesDec. 2016: Heavy silicone oil—SF6 exchange; gas removal from anterior chamber four days later.No data (surgeries elsewhere)
No. 11Phakic RRDFeb. 2014Phaco-IOL, PPV, post. capsulotomy, ILMP with ICG, PFCL, EL, C2F6YesFeb. 2014: Anterior chamber revision due to intracameral gas, iris capture and pupillary blockJan. 2016
No. 12Pseudophakic RRDJan. 2013PPV, PFCL, EL, airNoFeb. 2013: repeat PPV, EL, MP, retinectomy, 5000 cs silicone oil; Sep. 2013: silicone–air exchange; Oct. 2013: YAG-laser capsulotomyAug 2015
No. 13Phakic RRDJul. 2009Phaco-IOL, PPV, MP, PFCL, EL, silicone oilNoNov. 2009: silicone removal and fluid–air exchange; Nov 2010: Iris fixation of dislocated IOLMay 2011
No. 14Pseudophakic RRDMay 2015PPV, PFCL, EL, C3F8YesNoneOct 2015
PPV: pars plana vitrectomy; RRD: rhegmatogenous retinal detachment; post: posterior; ILMP: internal limiting membrane peeling; PFCL: perfluorocarbon liquid; EL: endolaser; Phaco-IOL: phacoemulsification and intraocular lens implantation; ICG: indocyanine green; C2F6: hexafluoroethane; C3F8: perfluoropropane; SF6: Sulfur hexafluoride; SBS: scleral buckling surgery; MP: membrane peeling; IOL: intraocular lens.
Table
Table 3. Clinical data before and after diagnosis of intraocular lens opacifications.
Table 3. Clinical data before and after diagnosis of intraocular lens opacifications.
Patient No.Date of First Air/Gas Contact to IOLOpacification First DocumentedExplantation DateSecond IOLBCVA (logMAR) after PPVBCVA (logMAR) Prior to IOL ExplantationBCVA (logMAR) after IOL Exchange
No. 1May 2013July 201316 June 2015Alcon MA50BM (sulcus-fix)0.200.300.10
No. 2Aug. 2016Nov. 201611 December 2016None (patient left aphakic)1.302.802.30
No. 3Mar. 2014Aug. 20143 May 2016Avansee PU6AS Kowa (sulcus-fix)0.400.500.30
No. 4Sep. 2011Apr. 201324 January 2017Avansee PU6AS Kowa (sulcus-fix)0.100.400.30
No. 5June 2012Dec. 201616 January 2017Avansee PU6AS Kowa (sulcus-fix)0.300.300.30
No. 6Dec. 2014Dec. 201519 July 2016AMO VRSA54 (Artisan-retropupillary-fix)0.400.400.50
No. 7Jan. 2015July 20179 May 2017Avansee PU6AS Kowa (sulcus-fix)0.000.100.00
No. 8Nov. 2013Jan. 20148 August 2016Avansee PU6AS Kowa (sulcus-fix)0.100.500.10
No. 9No dataNo data31 October 2016Avansee PU6AS (sulcus-fix)0.700.701.00
No. 10No dataNo data18 May 2017Avansee PU6AS Kowa (sulcus-fix)n.b.0.500.40
No. 11Feb. 2014Jan. 20164 March 2016Alcon MA50BM (sulcus-fix)0.100.300.10
No. 12Jan. 2013Aug. 20155 October 2015Freedom Lens (sulcus-fix)1.001.300.70
No. 13Nov. 2009May 201115 December 2015Sensar AR40E (sulcus-fix)1.001.000.70
No. 14May 2015Oct. 20158 November 2015Alcon MA60AC (sulcus-fix)0.100.400.00
IOL: intraocular lens; BCVA: best corrected visual acuity; sulcus-fix: sulcus fixation of intraocular lens; retropupillary fix: retropupillary iris fixation of an artisan-type iris claw lens.
Table
Table 4. Characteristics of the calcified intraocular lenses.
Table 4. Characteristics of the calcified intraocular lenses.
IOL BrandMaterialDesignNo. of Eyes
(n: 14)
CT Asphina 409MHydrophilic acrylic with hydrophobic coatingSingle-piece, plate haptic4
B1AW00
Basis Z		Hydrophilic acrylicSingle-piece, c-loop haptic4
Rayner 970CHydrophilic acrylicSingle-piece, c loop haptic1
AcriLyc 44SHydrophilic acrylic with hydrophobic coatingSingle-piece, plate haptic1
Polylens AS61Hydrophilic acrylicThree-piece, c-loop haptic1
Acriva UD613Hydrophilic acrylic with hydrophobic coatingSingle-piece, c-loop haptic2
Unknownnot applicable.Single-piece, plate haptic1
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bopp, S.; Özdemir, H.B.; Aktaş, Z.; Khoramnia, R.; Yildirim, T.M.; Schickhardt, S.; Auffarth, G.U.; Özdek, Ş. Clinical Characteristics of Patients with Intraocular Lens Calcification after Pars Plana Vitrectomy. Diagnostics 2023, 13, 1943. https://doi.org/10.3390/diagnostics13111943

AMA Style

Bopp S, Özdemir HB, Aktaş Z, Khoramnia R, Yildirim TM, Schickhardt S, Auffarth GU, Özdek Ş. Clinical Characteristics of Patients with Intraocular Lens Calcification after Pars Plana Vitrectomy. Diagnostics. 2023; 13(11):1943. https://doi.org/10.3390/diagnostics13111943

Chicago/Turabian Style

Bopp, Silvia, Hüseyin Baran Özdemir, Zeynep Aktaş, Ramin Khoramnia, Timur M. Yildirim, Sonja Schickhardt, Gerd U. Auffarth, and Şengül Özdek. 2023. "Clinical Characteristics of Patients with Intraocular Lens Calcification after Pars Plana Vitrectomy" Diagnostics 13, no. 11: 1943. https://doi.org/10.3390/diagnostics13111943

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop